Outcomes in hospitalised patients with sepsis, severe sepsis or septic shock and reported penicillin allergy: a retrospective cohort study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35197334.
- Also identified by DOI 10.1136/bmjopen-2021-050879 and PMC identifier 8867335.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine outcomes in hospitalised patients with sepsis and reported penicillin allergy (PcnA). Observational retrospective cohort study using data from electronic health records. A large single health system with 11 hospitals of small, medium and large sizes including a 630-bed tertiary care teaching hospital. Patients (n=5238) ≥18 years of age, hospitalised with sepsis, severe sepsis or septic shock between 1 January 2016 and 31 December 2018, received antibacterial agents, and had documented PcnA status. Patients <18 years of age at admission were excluded. Primary outcomes evaluated were inpatient mortality and 30-day mortality posthospital discharge. Secondary outcomes were hospital length of stay, 30-day readmissions, duration of antibiotic use, rate of <i>Clostridium difficile</i> infection and total cost of care. There was no difference in outcomes including inpatient or 30-day mortality, hospital length of stay, in-hospital antibiotic duration, <i>C. difficile</i> infection, total cost of care and 30-day readmission rate between patients labelled with a PcnA vs patients who did not report PcnA (non-PcnA). In this retrospective single health system study, there was no difference in key outcomes including inpatient or 30-day mortality in patients admitted with sepsis and reported PcnA compared with patients who reported no PcnA.
Medical subject headings
- Clostridioides difficile
- Drug Hypersensitivity
- Sepsis
- Shock, Septic